Skip to Main Content

INFORMATION FOR

Bonnie Gould Rothberg

MD, PhD, MPH
Assistant Professor Adjunct of Epidemiology (Chronic Diseases); Attending Physician, Smilow Cancer Hospital

Research Summary

As an Oncology Hospitalist, I am interested in understanding patient- and systems-based metrics that can impact the quality or value of an Inpatient or Urgent Care encounter and in developing processes that can improve the quality, value or patient experience of these encounters.

Coauthors

Research Interests

Epidemiology; Medical Oncology; Quality Control; Hospitalists

Public Health Interests

Cancer; Health Care Quality, Efficiency

Selected Publications

  • Impact of an oncology urgent care clinic on emergency department rates.Sedghi T, Canavan M, Gross C, Davidoff A, Gould Rothberg B, Strait M, Sinanis N, Adelson K. Impact of an oncology urgent care clinic on emergency department rates. Journal Of Clinical Oncology 2019, 37: 6615-6615. DOI: 10.1200/jco.2019.37.15_suppl.6615.
  • Meta-analysis of prognostic biomarkers for pancreatic neuroendocrine tumors (PNETs).Zhu M, Halfdanarson T, Gould Rothberg B. Meta-analysis of prognostic biomarkers for pancreatic neuroendocrine tumors (PNETs). Journal Of Clinical Oncology 2019, 37: e15688-e15688. DOI: 10.1200/jco.2019.37.15_suppl.e15688.
  • Survivorship Care for Older Adults With Cancer: The Role of Primary Care Physicians and Utility of Care Plans as a Communication ToolBellizzi K, Gould Rothberg B. Survivorship Care for Older Adults With Cancer: The Role of Primary Care Physicians and Utility of Care Plans as a Communication Tool 2017 DOI: 10.1891/9781617052828.0030.
  • Correlation of body mass index with female survival benefit among a single-institution cohort of cutaneous melanomas >1 mm thick following wide-local excision and sentinel lymph node biopsy.Jackson L, Bulloch K, Narayan D, Ariyan S, Gould Rothberg B. Correlation of body mass index with female survival benefit among a single-institution cohort of cutaneous melanomas >1 mm thick following wide-local excision and sentinel lymph node biopsy. Journal Of Clinical Oncology 2016, 34: 172-172. DOI: 10.1200/jco.2016.34.3_suppl.172.
  • The Yale Gastrointestinal Cancer Biorepository: A comprehensive biospecimen and data resource for studying determinants of pancreatic ductal adenocarcinoma prognosis following curative-intent pancreaticoduodenectomy.Gould Rothberg B, Deminie C, Lazowski H, Gibson J, Cha C, Lacy J, Hochster H, Salem R. The Yale Gastrointestinal Cancer Biorepository: A comprehensive biospecimen and data resource for studying determinants of pancreatic ductal adenocarcinoma prognosis following curative-intent pancreaticoduodenectomy. Journal Of Clinical Oncology 2015, 33: 272-272. DOI: 10.1200/jco.2015.33.3_suppl.272.
  • Role of adjuvant radiation in patients with squamous cell carcinomas of the oral cavity.Maron S, Gould Rothberg B, Otremba M, Judson B, Morgensztern D. Role of adjuvant radiation in patients with squamous cell carcinomas of the oral cavity. Journal Of Clinical Oncology 2013, 31: 6042-6042. DOI: 10.1200/jco.2013.31.15_suppl.6042.
  • Outcomes for stage IVA squamous cell carcinoma of the oral cavity according to staging subtypes.Marrone K, Otremba M, Groisberg R, Deshpande H, Crawford F, Acevedo-Gadea C, Gould Rothberg B, Judson B, Morgensztern D. Outcomes for stage IVA squamous cell carcinoma of the oral cavity according to staging subtypes. Journal Of Clinical Oncology 2013, 31: 6076-6076. DOI: 10.1200/jco.2013.31.15_suppl.6076.
  • Survival and cause of death in patients with refractory anemias.Zhang Y, Gould Rothberg B, Morgensztern D. Survival and cause of death in patients with refractory anemias. Journal Of Clinical Oncology 2013, 31: 7033-7033. DOI: 10.1200/jco.2013.31.15_suppl.7033.
  • Incidence and Outcomes for Low Risk Myelodysplastic Syndrome: A Surveillance, Epidemiology and End Results (SEER) StudyZhang Y, Podoltsev N, Gould Rothberg B, Dhodapkar M, Morgensztern D. Incidence and Outcomes for Low Risk Myelodysplastic Syndrome: A Surveillance, Epidemiology and End Results (SEER) Study Blood 2012, 120: 4944-4944. DOI: 10.1182/blood.v120.21.4944.4944.

Clinical Trials